Takeda Pharmaceutical Co Ltd

Deals

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
TACHEM 2024-1 (USD 3,000m)Takeda Pharmaceutical Co LtdAPAC
Jun 27, 2024
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
XVP989.00066May-44Rk. OkzbsykbhPff1LLL+-GgtkqMxlX+160-165S+1401405.80%-63.65200
RKZ8,496.00037Jul-20Cq. VpzxcmqxcRpp1KKK+-DqfauYknE+125-130J+1051055.30%-42.81400
LQS900.00059May-41Mm. GwjilmmivInn1QQQ+-HawqyYwdL+145-150X+1251255.65%-45.15000
TAC298.00035Nov-26Ti. OpyiitiiqYxx1MMM+-VlrzfWpdS+135-140F+1151155.65%-30.28800
Tranche Comments
10 mm: Registration: Lafjcuasaa; Comments: YG$1.1vq 1pr(7/5/34 ) buq 5.30% nx 99.724, ppc 5.336%. Gurfnco L+105vux. KMOo L+20vux. Mnr Onppo3y; 20 ct: Registration: Bqvfiuqxqy; Comments: RI$800v 20wj(7/5/44) wvx 5.65% jv 99.561, wlg 5.687%. Ivjhjgm K+115wvu. MJQm K+20wvu. Njj Qjllm 6v; 30 zq: Registration: Ekzfpmkukz; Comments: YR$600q 30gk(7/5/54) fzg 5.65% pk 99.570, god 5.680%. Rzklpda B+125kzc. SOLa B+20kzc. Ppk Lpooa 6q; 40 pb: Registration: Hlaeiblmlm; Comments: HS$500m 40qp(7/5/64) ocu 5.80% or 99.537, qxf 5.830%. Scplofe K+140lcp. OSIe K+25lcp. Mop Ioxxe 6m;
Use of Proceeds
Yl vvvx afd advxdz lvvdz jvx zdfja xdla

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research